![Global Drug R&D Express (Apr 2024)](https://synapse-tour-cdn-patsnap-com.libproxy1.nus.edu.sg/synapse/open_resource/report/prod/data/report/20240624/3574/5fd1/aff8/93c8/35745fd1aff893c8_300w.webp)
Global Drug R&D Express (Apr 2024)
This report compiles and summarizes the basic information of all the first-to-market and special review drugs globally for the month of April totaling 90 drugs. Among them, 2 first-to-market drugs and 2 drugs under special review were selected for detailed analysis. The report provides an in-depth interpretation of these drugs, covering various aspects such as basic information, development status, technological barriers, mechanism of action, clinical trials, and competitive landscape.